Biontech Se Stock Price Prediction
| BNTX Stock | USD 114.00 3.03 2.73% |
Momentum 44
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.227 | EPS Estimate Next Quarter 3.31 | EPS Estimate Current Year (3.29) | EPS Estimate Next Year (3.42) | Wall Street Target Price 140.7658 |
Using BioNTech hype-based prediction, you can estimate the value of BioNTech SE from the perspective of BioNTech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards BioNTech using BioNTech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards BioNTech using crowd psychology based on the activity and movement of BioNTech's stock price.
BioNTech Short Interest
An investor who is long BioNTech may also wish to track short interest. As short interest increases, investors should be becoming more worried about BioNTech and may potentially protect profits, hedge BioNTech with its derivative instruments, or be ready for some potential downside.
200 Day MA 104.0002 | Short Percent 0.0549 | Short Ratio 3.76 | Shares Short Prior Month 2.6 M | 50 Day MA 117.3904 |
BioNTech SE Hype to Price Pattern
Investor biases related to BioNTech's public news can be used to forecast risks associated with an investment in BioNTech. The trend in average sentiment can be used to explain how an investor holding BioNTech can time the market purely based on public headlines and social activities around BioNTech SE. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of BioNTech's market sentiment to its price can help taders to make decisions based on the overall investors consensus about BioNTech.
BioNTech Implied Volatility | 0.61 |
BioNTech's implied volatility exposes the market's sentiment of BioNTech SE stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if BioNTech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that BioNTech stock will not fluctuate a lot when BioNTech's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in BioNTech to buy its stock at a price that has no basis in reality. In that case, they are not buying BioNTech because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BioNTech after-hype prediction price | USD 113.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current BioNTech contract
Based on the Rule 16, the options market is currently suggesting that BioNTech SE will have an average daily up or down price movement of about 0.0381% per day over the life of the 2025-04-17 option contract. With BioNTech trading at USD 114.0, that is roughly USD 0.0435 . If you think that the market is fully incorporating BioNTech's daily price movement you should consider acquiring BioNTech SE options at the current volatility level of 0.61%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
BioNTech |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioNTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioNTech After-Hype Price Prediction Density Analysis
As far as predicting the price of BioNTech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioNTech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BioNTech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BioNTech Estimiated After-Hype Price Volatility
In the context of predicting BioNTech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioNTech's historical news coverage. BioNTech's after-hype downside and upside margins for the prediction period are 110.90 and 116.98, respectively. We have considered BioNTech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BioNTech is very steady at this time. Analysis and calculation of next after-hype price of BioNTech SE is based on 3 months time horizon.
BioNTech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BioNTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioNTech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioNTech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 3.04 | 0.06 | 0.02 | 10 Events / Month | 0 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
114.00 | 113.94 | 0.05 |
|
BioNTech Hype Timeline
BioNTech SE is currently traded for 114.00. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.02. BioNTech is anticipated to decline in value after the next headline, with the price expected to drop to 113.94. The average volatility of media hype impact on the company price is about 96.82%. The price decrease on the next news is expected to be -0.05%, whereas the daily expected return is currently at -0.02%. The volatility of related hype on BioNTech is about 381.43%, with the expected price after the next announcement by competition of 114.02. About 63.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioNTech SE has Price/Earnings To Growth (PEG) ratio of 0.04. The entity recorded a loss per share of 2.09. The firm last dividend was issued on the 2nd of June 2022. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out BioNTech Basic Forecasting Models to cross-verify your projections.BioNTech Related Hype Analysis
Having access to credible news sources related to BioNTech's direct competition is more important than ever and may enhance your ability to predict BioNTech's future price movements. Getting to know how BioNTech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioNTech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BEAM | Beam Therapeutics | 0.00 | 0 per month | 4.16 | 0.03 | 8.04 | (8.20) | 22.67 | |
| EDIT | Editas Medicine | 0.00 | 0 per month | 9.00 | 0.03 | 12.20 | (11.18) | 119.53 | |
| CRBU | Caribou Biosciences | 0.00 | 0 per month | 0.00 | (0.23) | 8.22 | (8.02) | 17.32 | |
| VERV | Verve Therapeutics | 0.00 | 0 per month | 4.95 | 0.06 | 11.28 | (8.25) | 36.90 | |
| NTLA | Intellia Therapeutics | 0.00 | 0 per month | 0.00 | (0.11) | 9.25 | (7.56) | 22.98 | |
| FATE | Fate Therapeutics | 0.00 | 0 per month | 0.00 | (0.23) | 11.34 | (12.24) | 27.52 | |
| REGN | Regeneron Pharmaceuticals | 7.97 | 7 per month | 0.00 | (0.04) | 2.15 | (3.61) | 8.14 | |
| NVO | Novo Nordisk AS | 0.00 | 0 per month | 0.00 | (0.07) | 5.18 | (4.07) | 20.12 | |
| SRPT | Sarepta Therapeutics | 0.00 | 0 per month | 0.00 | (0.19) | 2.49 | (4.38) | 10.14 | |
| HEPA | Hepion Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.11) | 29.41 | (18.18) | 86.86 |
BioNTech Additional Predictive Modules
Most predictive techniques to examine BioNTech price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioNTech using various technical indicators. When you analyze BioNTech charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BioNTech Predictive Indicators
The successful prediction of BioNTech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BioNTech SE, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BioNTech based on analysis of BioNTech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BioNTech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BioNTech's related companies. | 2024 | 2025 (projected) | Dividend Yield | 0.0123 | 0.011 | Price To Sales Ratio | 6.88 | 6.54 |
Story Coverage note for BioNTech
The number of cover stories for BioNTech depends on current market conditions and BioNTech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioNTech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioNTech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
BioNTech Short Properties
BioNTech's future price predictability will typically decrease when BioNTech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BioNTech SE often depends not only on the future outlook of the potential BioNTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioNTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 242.7 M | |
| Cash And Short Term Investments | 16.5 B |
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.